![]() |
|
Increasingly, biopharmaceutical companies have begun to incorporate QbD approaches that utilize inline monitoring to achieve continuous process verification, process control, or real-time release. Real-time release necessitates a more conservative approach to PAT implementation, whereas process control and continuous verification may necessitate a more progressive approach. Determining which approach to take is critical to a process control strategy.
|